Human Adenovirus Type 55 Distribution, Regional Persistence, and Genetic Variability.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 22 6 2021
Statut: ppublish

Résumé

Human adenovirus type 55 (HAdV-55) causes acute respiratory disease of variable severity and has become an emergent threat in both civilian and military populations. HAdV-55 infection is endemic to China and South Korea, but data from other regions and time periods are needed for comprehensive assessment of HAdV-55 prevalence from a global perspective. In this study, we subjected HAdV-55 isolates from various countries collected during 1969-2018 to whole-genome sequencing, genomic and proteomic comparison, and phylogenetic analyses. The results show worldwide distribution of HAdV-55; recent strains share a high degree of genomic homogeneity. Distinct strains circulated regionally for several years, suggesting persistent local transmission. Several cases of sporadic introduction of certain strains to other countries were documented. Among the identified amino acid mutations distinguishing HAdV-55 strains, some have potential impact on essential viral functions and may affect infectivity and transmission.

Identifiants

pubmed: 32568062
doi: 10.3201/eid2607.191707
pmc: PMC7323512
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1497-1505

Références

J Korean Med Sci. 2017 Feb;32(2):287-295
pubmed: 28049240
J Clin Microbiol. 2004 Apr;42(4):1686-93
pubmed: 15071026
MMWR Morb Mortal Wkly Rep. 1998 Jul 17;47(27):567-70
pubmed: 9694642
J Med Virol. 2017 Aug;89(8):1387-1394
pubmed: 28198541
Front Microbiol. 2018 Jun 05;9:1180
pubmed: 29922263
Emerg Infect Dis. 2017 Jan;23(1):95-98
pubmed: 27748651
J Infect Dis. 2015 Sep 15;212(6):871-80
pubmed: 25748322
J Virol. 2012 Nov;86(22):12441-2
pubmed: 23087107
BMC Bioinformatics. 2015 Dec 29;16:416
pubmed: 26714571
Clin Microbiol Rev. 2015 Jul;28(3):743-800
pubmed: 26085551
J Clin Microbiol. 2009 Oct;47(10):3082-90
pubmed: 19675212
Curr Top Microbiol Immunol. 2003;272:131-64
pubmed: 12747549
Emerg Infect Dis. 2018 Jul;24(7):1221-1227
pubmed: 29912713
Emerg Infect Dis. 2016 Nov;22(11):2012-2014
pubmed: 27767916
Infect Dis (Lond). 2016;48(1):40-7
pubmed: 26465201
Front Microbiol. 2018 Sep 11;9:2178
pubmed: 30254627
J Clin Virol. 2013 Sep;58(1):4-10
pubmed: 23886503
Emerg Infect Dis. 2019 Sep;25(9):1756-1758
pubmed: 31441750
Am J Epidemiol. 1974 Jun;99(6):434-42
pubmed: 4367031
BMC Infect Dis. 2014 Dec 05;14:576
pubmed: 25475044
J Virol. 2012 Dec;86(24):13554-65
pubmed: 23035217
Emerg Infect Dis. 2017 Jun;23(6):1016-1020
pubmed: 28518038
J Gen Virol. 2001 Aug;82(Pt 8):1917-1927
pubmed: 11457998
Intervirology. 1991;32(6):338-50
pubmed: 1657824
Nucleic Acids Res. 2017 Jan 9;45(1):67-80
pubmed: 27899609
J Med Virol. 2005 Oct;77(2):232-7
pubmed: 16121380
Genome Announc. 2017 Mar 9;5(10):
pubmed: 28280019
Influenza Other Respir Viruses. 2014 May;8(3):302-8
pubmed: 24467816
Clin Infect Dis. 2002 Oct 1;35(7):808-18
pubmed: 12228817
J Med Virol. 2001 Dec;65(4):710-8
pubmed: 11745936
Clin Infect Dis. 2000 Sep;31(3):663-70
pubmed: 11017812
Vaccine. 2013 Jun 19;31(28):2963-71
pubmed: 23623865
Disaster Med Public Health Prep. 2018 Aug;12(4):464-469
pubmed: 26915755
PLoS One. 2017 Jan 23;12(1):e0170592
pubmed: 28114362
Int J Infect Dis. 2014 Nov;28:117-22
pubmed: 25236387
Emerg Microbes Infect. 2017 Jun 7;6(6):e43
pubmed: 28588291
J Clin Virol. 2013 Dec;58(4):741-2
pubmed: 24161575
PLoS One. 2017 Dec 14;12(12):e0189625
pubmed: 29240811
Emerg Microbes Infect. 2018 Feb 7;7(1):10
pubmed: 29410402
J Clin Microbiol. 2010 Mar;48(3):991-3
pubmed: 20042633
Curr Opin Virol. 2019 Feb;34:63-69
pubmed: 30654272
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
J Clin Virol. 2016 May;78:31-5
pubmed: 26971165
Korean J Intern Med. 2019 Sep 05;:
pubmed: 31480827
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Infect Immun. 1976 Feb;13(2):354-9
pubmed: 177365
J Clin Microbiol. 2004 Sep;42(9):3963-9
pubmed: 15364976
PLoS One. 2016 Aug 17;11(8):e0160777
pubmed: 27532864
Sci Rep. 2019 Jan 31;9(1):1039
pubmed: 30705303
Arch Virol. 2016 Sep;161(9):2481-9
pubmed: 27352268

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH